Skip to main content
. 2011 Sep 28;23(5):1121–1129. doi: 10.1093/annonc/mdr412

Figure 4.

Figure 4.

Meta-analysis on disease-free survival of main taxane first-generation adjuvant/neoadjuvant trials.